NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working.
|
|
Join the NPC evidence-based therapeutics team as they discuss some important recent studies and therapeutic news. This month:
- No significant benefits for early detection and intensive multifactorial management of type 2 diabetes
- SHARP RCT shows ezetimibe/simvastatin reduces CV events in CKD: but is it better than simvastatin alone?
- New safety information for pioglitazone▼, dronedarone▼, varenicline▼, and Pandemrix®▼
Please click on the hyperlink above to access the Rapid Review on this topic
The podcast lasts 13:34 minutes.
[display_podcast]
 |
Subscribe to the NPC podcast via the iTunes store |
 |
Subscribe to the NPC podcast via RSS feed |